People | February 20, 2022
Resolution Therapeutics strengthens its team with two new appointments
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Expands manufacturing push & locks in major growth deals
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Subscribe To Our Newsletter & Stay Updated
